Using measured cannabidiol and tetrahydrocannabinol metabolites in urine to differentiate marijuana use from consumption of commercial cannabidiol products
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Toxicology"
DOI: 10.1080/15563650.2020.1827148
Abstract: Abstract Context Detecting marijuana use is a component of most urine drug screens targeting a single Δ9-tetrahydrocannabinol metabolite. Recently, the non-intoxicating cannabinoid, cannabidiol (CBD), has gained popular acceptance for a myriad of reasons. Commercially available… read more here.
Keywords: marijuana use; tetrahydrocannabinol metabolites; cbd; tetrahydrocannabinol ... See more keywords